Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.

Drain, Paul K.Gounder, Lilishia.Grobler, Anna Christina.Sahid, Faieza.Bassett, Ingrid V.Moosa, Mahomed Yunus Suleman.2016-11-162016-11-1620152015Drain, P.K., Gounder, L., Grobler, A., Sahid, F., Bassett, I.V. and Moosa, M.Y.S. 2015. Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study. BMJ open 5(4), e006833.http://dx.doi.org/10.1136/bmjopen-2014-006833http://hdl.handle.net/10413/13710CAPRISA, 2015.Abstract available in pdf.enAntitubercular Agents.Biomarkers.CD4 Lymphocyte Count.Endemic Diseases.HIV Infections.Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.Peer reviewed journal article